These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4664488)

  • 1. [Peridural anesthesia. 3. Its usefulness in therapy of acute and chronic arteriopathies].
    Raso AM; Silvestrini P
    Chirurgia (1951); 1972 Aug; 21(8):743-6. PubMed ID: 4664488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of acute and chronic arteriopathies with chenical sympathicolysis by means of peridural infiltration].
    Raso AM; Silvestrini P; Roviera C
    Angiologia; 1974; 26(2):71-4. PubMed ID: 4451291
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current trends in medical therapy of chronic peripheral obliterating arteriopathies].
    Peruzzi G; Tallarida G; Baldoni F; Raimondi G; Grimaldi I; Sangiorgi M
    Clin Ter; 1985 Jul; 114(1):3-26. PubMed ID: 2864161
    [No Abstract]   [Full Text] [Related]  

  • 5. [The vasoactivogram in the treatment of peripheral arteriopathies].
    Romeo S; Spinella G; Sciacchitanto D
    Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medical therapy of acute peripheral ischemia].
    Basellini A; Martelli E; Losa S
    Minerva Med; 1985 Mar; 76(11):501-3. PubMed ID: 3982684
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of thymoxamine in peripheral arterial pathology].
    Ghiglino GC; Viacava A; Gori A; Misuri A; Lucertini G; Pelagatti M
    Clin Ter; 1983 Apr; 105(2):103-7. PubMed ID: 6222862
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
    Natali J; Kieny R; Le Bas P; Benhamou M; Molkhou JM
    Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):339-42. PubMed ID: 2667444
    [No Abstract]   [Full Text] [Related]  

  • 10. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sense and nonsense in vasodilatory therapy].
    Thiele P
    Z Arztl Fortbild (Jena); 1977 Apr; 71(8):393-6. PubMed ID: 878509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current diagnostic and therapeutic aspects of chronic arterial diseases].
    Okos G; Lamboy L
    Orv Hetil; 1969 Dec; 110(49):2861-4. PubMed ID: 5364764
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract]   [Full Text] [Related]  

  • 16. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
    Giubbolini G; Setacci C; Romei R; Federici L
    Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical therapy of obliterating arteriopathies].
    Schwarz D
    Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of arteriosclerotic circulatory disorders].
    Nobbe F
    Z Allgemeinmed; 1974 Jul; 50(21):957-64. PubMed ID: 4152664
    [No Abstract]   [Full Text] [Related]  

  • 19. [Surheme in chronic obliterative arteriopathies of the lower limbs].
    Desruelles J; Waucampt JJ
    Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
    [No Abstract]   [Full Text] [Related]  

  • 20. [Systemic and selective streptokinase therapy in arterial occlusions].
    Hess H
    Internist (Berl); 1982 Jul; 23(7):405-9. PubMed ID: 6213579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.